Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
FEBS Lett ; 499(3): 199-204, 2001 Jun 22.
Artículo en Inglés | MEDLINE | ID: mdl-11423116

RESUMEN

A wealth of evidence correlates the chemopreventive activity of a fiber-rich diet with the production of butyrate. In order to identify the genes transcriptionally modulated by the molecule, we analyzed the expression profile of butyrate-treated colon cancer cells by means of cDNA expression arrays. Moreover, the effect of trichostatin A, a specific histone deacetylase inhibitor, was studied. A superimposable group of 23 genes out of 588 investigated is modulated by both butyrate and trichostatin A. Among them, a major target was tob-1, a gene involved in the control of cell cycle. tob-1 is also up-regulated by butyrate in a neuroblastoma-derived cell line, and its overexpression in the colon cells caused growth arrest. Our findings represent an extensive analysis of genes modulated by butyrate and identify completely new effectors of its biological activities.


Asunto(s)
Butiratos/farmacología , Proteínas de Unión al ADN/genética , Expresión Génica/efectos de los fármacos , Histonas/metabolismo , Factores de Transcripción/genética , Acetilación , Neoplasias del Colon , Cicloheximida/farmacología , Proteínas de Unión al ADN/metabolismo , Inhibidores Enzimáticos/farmacología , Factor de Transcripción GATA2 , Perfilación de la Expresión Génica , Células HT29 , Inhibidores de Histona Desacetilasas , Histona Desacetilasas/metabolismo , Histonas/fisiología , Humanos , Ácidos Hidroxámicos/farmacología , Análisis de Secuencia por Matrices de Oligonucleótidos , Inhibidores de la Síntesis de la Proteína/farmacología , ARN Mensajero/efectos de los fármacos , ARN Mensajero/metabolismo , Factores de Transcripción/metabolismo , Células Tumorales Cultivadas
2.
Biochem Biophys Res Commun ; 268(3): 942-6, 2000 Feb 24.
Artículo en Inglés | MEDLINE | ID: mdl-10679310

RESUMEN

Pyrrolidine dithiocarbamate (PDTC) is a synthetic antioxidant molecule, which has been recently proposed as an antitumoral agent on the basis of its capability of inducing apoptosis. We investigated the effect of PDTC on the proliferation and survival of the promyelocitic cell line HL-60. Concentration as low as 10 microM of PDTC induces a significant reduction of the growth rate and the contemporaneous activation of the apoptotic process. Programmed cell death was demonstrated by biochemical analyses, including the activation of procaspase 3 and the cleavage of poly(ADP-ribose) polymerase (PARP). PDTC-dependent apoptosis was associated with an early release of cytochrome c from mitochondria, while the involvement of pathways due to cell death receptors engagement was ruled out by detailed time-course analyses of caspases 3 and 8 activation. Moreover, no up-regulation of p21(CIP1) level, a pivotal cyclin-dependent kinase inhibitor, occurred at PDTC concentration able to induce apoptosis. Finally, in vitro incubation of purified mitochondria with PDTC demonstrated that the molecule is directly able to induce cytochrome c release from the intermembrane space, thus confirming that mitochondria are a primary cellular target of the molecule.


Asunto(s)
Antioxidantes/farmacología , Apoptosis/efectos de los fármacos , Grupo Citocromo c/metabolismo , Pirrolidinas/farmacología , Tiocarbamatos/farmacología , Apoptosis/fisiología , Caspasa 8 , Caspasa 9 , Caspasas/metabolismo , División Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Proteína Ligando Fas , Células HL-60 , Humanos , Glicoproteínas de Membrana/metabolismo , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Poli(ADP-Ribosa) Polimerasas/metabolismo
3.
Eur J Immunol ; 29(6): 1879-89, 1999 06.
Artículo en Inglés | MEDLINE | ID: mdl-10382750

RESUMEN

The pathogenesis of the decline of CD4 lymphocyte counts accompanying the typical course of HIV-1 infection is not completely defined and might be related to a differential susceptibility of naive and memory cells to HIV-1 exposure. Here, we examined the effects induced by heat-inactivated HIV-1 virions on these lymphocyte populations. Exposure of CD45RA naive T cells to inactivated viral particles induced a marked decrease of both mitogenic responses and activation-induced apoptosis. Conversely, the growth of CD45RO cells was less severely restrained. Analysis of intracellular levels of cell cycle regulatory proteins revealed an arrest at the G1/S restriction point of the naive but not memory subset. This effect was associated with alterations in phosphotyrosine profile and with a marked decrease of ERK and NJK kinase activation. Finally, up-regulation of the cAMP-dependent protein kinase A (PKA) activity induced by mitogens was not affected by virus. Altogether, these findings show that interaction of HIV-1 with the T cell surface is sufficient to inhibit the proliferative response of the CD4CD45RA subset by disturbing proximal TCR signaling. This mechanism would affect renewal of naive lymphocytes, contributing in such a way to the impairment of T cell turnover during the course of HIV-1 infection.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Quinasas CDC2-CDC28 , VIH-1/inmunología , VIH-1/patogenicidad , Activación de Linfocitos , Apoptosis/inmunología , Linfocitos T CD4-Positivos/metabolismo , Linfocitos T CD4-Positivos/patología , Proteínas Quinasas Dependientes de Calcio-Calmodulina/metabolismo , Ciclo Celular , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Ciclina D3 , Quinasa 2 Dependiente de la Ciclina , Quinasas Ciclina-Dependientes/metabolismo , Ciclinas/metabolismo , Activación Enzimática , Infecciones por VIH/inmunología , Infecciones por VIH/patología , Calor , Humanos , Memoria Inmunológica , Técnicas In Vitro , Antígenos Comunes de Leucocito/metabolismo , Fosfotirosina/metabolismo , Proteínas Serina-Treonina Quinasas/metabolismo , Proteína Tirosina Fosfatasa no Receptora Tipo 1 , Transducción de Señal/inmunología
6.
Biochem Biophys Res Commun ; 233(3): 673-7, 1997 Apr 28.
Artículo en Inglés | MEDLINE | ID: mdl-9168912

RESUMEN

Butyrate, a dietary fiber derivative, is a well-known differentiating agent in cultured cell lines. In addition, its antineoplastic activity toward colon-rectum cancers has been documented both in vivo and in vitro. Despite the large amount of information on the potential clinical efficacy of butyrate, its mechanism of action at the molecular level has only been partially investigated. Here, we show that serine/threonine protein kinase CKII is a target of butyrate activity. In the human adenocarcinoma cell line, HT29, treated with 2 mM sodium butyrate, CKII activity decreases 50% at 24 and 48 hours after drug addition. The enzyme down-regulation is not due to changes in protein amount since the levels of the different CKII subunits remain constant during butyrate treatment. The data reported provide the first evidence that CKII down-regulation is involved in the signal transduction pathway started by butyrate.


Asunto(s)
Butiratos/farmacología , Proteínas Serina-Treonina Quinasas/antagonistas & inhibidores , Adenocarcinoma/enzimología , Secuencia de Aminoácidos , Ácido Butírico , Quinasa de la Caseína II , Diferenciación Celular/efectos de los fármacos , Neoplasias del Colon/enzimología , Regulación hacia Abajo/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Humanos , Oligopéptidos/química , Proteínas Serina-Treonina Quinasas/metabolismo , Transducción de Señal/efectos de los fármacos , Especificidad por Sustrato , Células Tumorales Cultivadas
7.
Biochem Biophys Res Commun ; 231(1): 73-6, 1997 Feb 03.
Artículo en Inglés | MEDLINE | ID: mdl-9070222

RESUMEN

Characterization of proteins that control the passage through the G1 phase of the cell cycle is of particular interest because virtually all stimuli regulating cell proliferation or differentiation act primarily during this phase. We have analyzed the G1 phase proteic machinery, including cyclin D types, cyclin-dependent kinases (CDKs) and CDK inhibitors, of cell populations obtained at different stages of hematopoietic cell lineage. In particular, five cellular phenotypes, namely CD34+ cells (which contain stem cells), BFU-E, CFU-E, CFU-GM and peripheral lymphocytes were studied as representatives of distinct differentiation pathways. The results obtained indicated that all the cellular preparations express cyclin D2 and D3, while cyclin D1, which is the major cyclin D occurring in mesenchimal tissues, is not expressed. Moreover, CDK6 (but not CDK4) was detectable in all the populations investigated. Among the CDK inhibitors studied, p18INK4C and p19INK4D signals were clearly evidentiable in the various cell types. Interestingly, high levels of p15INK4B, a putative tumor suppressor protein, were detectable especially in granulocyte-monocyte precursors. Our results indicate that a specific hematopoietic G1 phase machinery occurs, which is conserved during the various steps of the different maturation processes.


Asunto(s)
Fase G1 , Regulación de la Expresión Génica , Hematopoyesis , Células Madre Hematopoyéticas/citología , Linfocitos/citología , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Diferenciación Celular , Linaje de la Célula , Ciclina D , Quinasas Ciclina-Dependientes/antagonistas & inhibidores , Quinasas Ciclina-Dependientes/genética , Quinasas Ciclina-Dependientes/metabolismo , Ciclinas/genética , Ciclinas/metabolismo , Eritroblastos/citología , Eritroblastos/metabolismo , Granulocitos/citología , Granulocitos/metabolismo , Células Madre Hematopoyéticas/metabolismo , Humanos , Linfocitos/metabolismo , Macrófagos/citología , Macrófagos/metabolismo
8.
Biochem Biophys Res Commun ; 223(3): 514-9, 1996 Jun 25.
Artículo en Inglés | MEDLINE | ID: mdl-8687427

RESUMEN

5'-Methylthioadenosine phosphorylase gene maps on the 9p21 chromosome, strictly linked to the important tumor suppressor gene p16INK4A. Chromosomal deletions encompassing both the phosphorylase and p16INK4A genes cause the complete absence of the enzymatic activity in a large number of tumors, thus resulting in well-defined metabolic differences between malignant and normal cells. Recently, the cloning of the phosphorylase gene has been reported on the basis of indirect evidence. In order to demonstrate definitely the identification of 5'-methylthioadenosine phosphorylase gene, we have cloned the putative enzyme coding sequence in a prokaryotic expression vector and expressed the protein in bacteria. The recombinant phosphorylase has been purified to homogeneity and its physicochemical, immunological and kinetic features have been characterized. The results obtained allowed the conclusive demonstration of 5'-methylthioadenosine phosphorylase gene cloning and the use of recombinant protein for further characterization.


Asunto(s)
Purina-Nucleósido Fosforilasa/aislamiento & purificación , Purina-Nucleósido Fosforilasa/metabolismo , Cromatografía en Gel , Cromatografía por Intercambio Iónico , Mapeo Cromosómico , Cromosomas Humanos Par 9 , Clonación Molecular , ADN Complementario , Inhibidores Enzimáticos/farmacología , Escherichia coli , Ligamiento Genético , Humanos , Isopropil Tiogalactósido/farmacología , Peso Molecular , Fosfatos/farmacología , Purina-Nucleósido Fosforilasa/genética , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo , Especificidad por Sustrato
9.
Kidney Int ; 45(2): 451-60, 1994 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8164433

RESUMEN

Human proximal tubular epithelial cells (PTEC) incubated with normal human serum (NHS) were found to fix on their surface C3, properdin, terminal complement components and C5b-9 MAC neoantigen, but not C1q and C4, by immunofluorescence. Complement fixation was abrogated if PTEC were incubated with EDTA-treated NHS or C3-deficient human serum, but not with Mg EGTA-treated NHS or C1q-deficient human serum, showing the prevalent activation of the alternative pathway of complement. This event was followed by marked cytoskeleton alterations with disruption of the actin cortical network, redistribution of actin throughout the cytoplasm and formation of blebs, and by cell cytolysis. In addition, superoxide anion and hydrogen peroxide production and chemiluminescence response were detected in consequence of MAC insertion on PTEC plasma membrane. The dependency on MAC of the observed biological effects of complement fixation on PTEC surface was shown by using sera selectively deficient of terminal components of complement (C6 or C8), and therefore unable to form the C5b-9 MAC, and by restoring the ability to form MAC after addition of purified C6 or C8. The possible pathogenetic relevance of these observations in tubulointerstitial injury occurring in patients with complementuria due to non-selective proteinuria, is discussed.


Asunto(s)
Vía Alternativa del Complemento , Túbulos Renales Proximales/metabolismo , Sangre , Membrana Celular/metabolismo , Células Cultivadas , Complejo de Ataque a Membrana del Sistema Complemento/metabolismo , Citoesqueleto/metabolismo , Células Epiteliales , Epitelio/metabolismo , Técnica del Anticuerpo Fluorescente , Humanos , Peróxido de Hidrógeno/metabolismo , Túbulos Renales Proximales/citología , Especies Reactivas de Oxígeno/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA